−211
Denali Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−245
FY23:
−358
FY24:
−348
FY25:
−413
Change from FY21 to FY25
millions USD
FY21:
−21.6
FY22:
−141
FY23:
249
FY24:
−88.8
FY25:
255
Change from FY21 to FY25
millions USD
FY21:
19.3
FY22:
311
FY23:
17.8
FY24:
484
FY25:
189
millions USD
FY21:
−214
FY22:
−75.4
FY23:
−90.9
FY24:
47.9
FY25:
31.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−220
FY22:
−263
FY23:
−371
FY24:
−364
FY25:
−422
All amounts in millions USD